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Abstract
Introduction: Platelet-rich plasma (PRP) is a fraction of plasma in which several growth factors are concentrated at
high levels. The active soluble releasate isolated following platelet activation of PRP (PRP-releasate) has been
demonstrated to stimulate the metabolism of IVD cells in vitro. The in vivo effect of PRP-releasate on degenerated
IVD remains unknown. The purpose of this study was to determine the reparative effects of autologous PRP-
releasate on degenerated intervertebral discs (IVDs).
Methods: To induce disc degeneration, New Zealand white rabbits (n = 12) received anular puncture in two
noncontiguous discs. Autologous PRP and PPP (platelet-poor plasma) were isolated from fresh blood using two
centrifugation techniques. Four weeks after the initial puncture, releasate isolated from clotted PPP or PRP (PPP- or
PRP-releasate), or phosphate-buffered saline (PBS; control) was injected into the punctured discs. Disc height,
magnetic resonance imaging (MRI) T2-mapping and histology were assessed.
Results: Anular puncture produced a consistent disc narrowing within four weeks. PRP-releasate induced a
statistically significant restoration of disc height (PRP vs. PPP and PBS, P<0.05). In T2-quantification, the mean T2-
values of the nucleus pulposus (NP) and anulus fibrosus (AF) of the discs were not significantly different among
the three treatment groups. Histologically, the number of chondrocyte-like cells was significantly higher in the discs
injected with PRP-releasate compared to that with PBS.
Conclusions: The administration of active PRP-releasate induced a reparative effect on rabbit degenerated IVDs.
The results of this study suggest that the use of autologous PRP-releasate is safe and can lead to a clinical
application for IVD degeneration.
Introduction
Intervertebral disc (IVD) degeneration is considered to
be a multifactorial process involving mechanical, genetic,
systemic, and biological factors. Biochemically, IVD
degeneration is characterized by a change in extracellu-
lar matrix molecules (loss of proteoglycan and water
content in the nucleus pulposus, or NP), resulting in an
alteration of the biomechanical properties of IVD tis-
sues. These degenerative changes are considered to
induce the disruption (radial and circumferential tears,
cracking, and fissuring) of IVD tissues, leading to degen-
erative disc diseases and, eventually, to low back pain
[1-4]. Unfortunately, because of the absence of blood
supply in the inner anulus fibrosus (AF) and NP, IVD
tissues have little potential for self-repair. Thus, experi-
mental treatment options for disc degeneration, encom-
passing molecular, gene, and cell therapies, are being
actively pursued [5].
To develop biological therapies for IVD repair, mole-
cular biology and tissue engineering technologies have
recently been applied to improve the micro-environment
of IVD tissues [6-14]. Growth factors are biologically
active molecules capable of stimulating cellular growth,
proliferation, and differentiation in an endocrine or
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paracrine fashion. Many growth factors, such as trans-
forming growth factor-b (TGF-b), insulin-like growth
factor-1 (IGF-1), basic fibroblast growth factor, platelet-
derived growth factor (PDGF), epidermal growth factor
(EGF), and bone morphogenetic protein (BMP)-2 and
BMP-7 (otherwise known as osteogenic protein-1, or
OP-1), have been shown to positively modulate the
extracellular matrix of IVD cells (see review in [15]).
Interestingly, in both in vitro and animal studies, autolo-
gous platelet-rich plasma (PRP), which contains concen-
trated levels of growth factors and other cytokines, has
been shown to provide a ‘local environment for tissue
regeneration’ [16]. Furthermore, the effective role of
PRP on tissue repair or regeneration (or both) in a
range of tissue types, including bone, cartilage, tendon,
and muscle, has been reported (see review in [16]).
The principal function of platelets is to prevent bleed-
ing. Platelets circulating in the blood rapidly adhere to
damaged endothelial tissues in response to vessel injury.
The activated platelets release plasma coagulation fac-
tors and adhesive protein, generating a fibrin clot. In
addition, activated platelets release a range of growth
factors (for example, IGF-1, TGF-b, PDGF, and EGF),
cytokines (for example, interleukin-1b [IL-1b] and IL-8),
and angiogenic factors (for example, vascular endothelial
growth factor and angiopoietin-1) [17,18]. These biologi-
cally active molecules synergically promote hemostasis
and tissue repair [17,19]. PRP is a plasma fraction that
contains platelets concentrated at a high level. Because
activated platelets have the potential to release growth
factors, including IGF-1, TGF-b, PDGF, and EGF, PRP
has been clinically used to accelerate wound healing and
tissue regeneration in orthopedic, oral-maxillofacial, and
plastic surgery [17,19,20]. Recently, the active soluble
releasate isolated from PRP has been demonstrated to
effectively stimulate the metabolism of articular chon-
drocytes [21] and IVD cells [22]in vitro. Therefore, we
hypothesized that the administration of PRP-releasate
into the degenerated IVD tissue could dramatically
change the metabolic homeostasis and micro-environ-
ment within the IVD and finally improve the potential
for self-repair. The purpose of this study was to deter-
mine the reparative effects of the in vivo administration
of autologous PRP-releasate into degenerated IVDs in a
well-established rabbit anular puncture model [23] using
radiologic, magnetic resonance imaging (MRI) T2 map-
ping, and histological analyses.
Materials and methods
Animal surgery and blood sampling
A rabbit anular puncture model of disc degeneration was
established, as previously reported [23]. Twelve female
New Zealand white rabbits (Kitayama Labes Laboratory
Animals Bleeding & Equipment Supply, Ina, Japan),
ranging from 2.9 to 3.4 kg in body weight, were used in
this study with the approval of our university’s Institu-
tional Animal Care and Use Committee. Preoperatively,
rabbits were anesthetized by an intramuscular injection of
ketamine hydrochloride (25 mg/kg; Ketalar; Sankyo
Seiyaku, Tokyo, Japan) mixed with xylazine (5 mg/kg;
Celactal; Bayer, Tokyo, Japan). Lateral plain radiographs
were obtained to determine baseline IVD height values
before puncture. Under general anesthesia with 3.0% iso-
flurane (Mylan Pharmaceutical Inc., Tampa, FL, USA),
lumbar IVDs were exposed through a posterolateral
approach, the initial puncture with an 18-gauge needle
was performed on two non-contiguous discs (L2/3 and
L4/5), and the disc (L3/4) between punctured discs was
left intact as a control [11]. During surgery, 10 mL of fresh
blood was drawn from the femoral artery with a 21-gauge
needle into a syringe treated with 1 mL of anti-coagulant
(citrate dextrose-A solution; Terumo, Tokyo, Japan). An
additional 5 mL of fresh blood was drawn to isolate auto-
logous serum to use in the activation step. The rabbits
were returned to their cages after a short recovery obser-
vation and mobilized ad libitum.
Preparation of platelet-rich plasma and platelet-poor
plasma releasates
PRP and PPP were prepared by using two centrifugation
techniques (Figure 1). Whole blood collected by using an
anti-coagulant was first centrifuged by using a centrifuga-
tion apparatus (Himac CT 6D; Hitachi Ltd., Tokyo,
Japan) for 15 minutes at 330g to separate plasma and
hemocyte fractions. The plasma fraction was then centri-
fuged for an additional 10 minutes at 1,000g. The super-
natant plasma (PPP) was carefully removed, and the
remaining PPP (approximately 200 μL) and precipitated
platelets were designated as PRP. The number of platelets
of each whole blood and PRP fraction was counted by
using a hemocytometer. Autologous serum was prepared
from the coagulated whole blood, which was centrifuged
for 10 minutes at 1,000g. To activate platelets, PRP and
PPP were treated with a mixture of autologous serum
and 2% CaCl2 (Otsuka Pharmaceutical, Tokyo, Japan) for
clot formation. The clotted PPP and PRP were allowed to
rest at room temperature for more than 30 minutes, fol-
lowed by centrifugation at 1,000g for 10 minutes. The
resulting soluble releasate from the clot preparation of
PRP (PRP-releasate) and PPP (PPP-releasate) was isolated
and kept at -80°C until used.
Experimental groups
Four weeks after the initial puncture, phosphate-buf-
fered saline (PBS) (control) or PPP- or PRP-releasate
was injected into the punctured discs through a contral-
ateral side approach. The anterolateral surfaces of the
previously punctured discs (L2/3-L4/5) were exposed
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with confirmation of osteophyte formation. Twelve rab-
bits were divided into two groups. One group (n = 4)
received an injection of PBS (20 μL) at L2/3 and L4/5
discs into the center of the NP by using a 30-gauge nee-
dle. For the remaining rabbits (n = 8), each rabbit
received one injection of PRP (20 μL) and one injection
of PPP (20 μL) randomly given between L2/3 and L4/5.
All preoperative and postoperative care was performed
as in the initial operation.
Radiographic analysis of disc height
Lateral plain radiographs of the lumbar spine were taken
after administration of ketamine hydrochloride (25 mg/
kg) and xylazine (5 mg/kg) at 2-week intervals up to 12
weeks after the initial puncture. Extreme care was taken
to maintain a consistent level of anesthesia during radio-
graphy of each animal and at each time to obtain a simi-
lar degree of muscle relaxation, which may affect the
disc height. All radiographic images were independently
analyzed by using OsiriX Medical Image software
(OsiriX Foundation, Geneva, Switzerland) by an ortho-
pedic researcher who was blinded to the treatment
groups. Data are reported as the IVD height expressed
as the disc height index (DHI) (DHI = IVD height/adja-
cent vertebral disc height) [11,23]. Change in the DHI
of injected discs was expressed as percentage DHI (%
DHI) and normalized to the measured preoperative IVD
height: % DHI = (postoperative DHI/preoperative DHI)
× 100 [11]. Non-responsive treated discs (which did not
exhibit degenerated changes at 4 weeks) were excluded
from the analysis.
Magnetic resonance imaging T2 quantification
Twelve weeks after the initial puncture, all rabbits were
sacrificed and the spinal columns (L1 to L6 vertebra) with
surrounding soft tissues were isolated and subjected to
quantitative T2 MRI analysis. MRI was performed by using
a 3.0-Tesla imager (Achieva 3.0T; Philips, Amsterdam, The
Netherlands) with a 3-inch birdcage extremity coil (Phi-
lips). Quantitative T2 mapping was performed by using a
multi-echo spin-echo sequence in the sagittal plane. Scan-
ning parameters were the following: time-to-repeat (TR) =
3,000 ms, time-to-echo (TE) = 20, 40, 400 ms (20 TEs),
field of view = 10 cm, slice thickness = 2 mm, image matrix
= 560 × 560, and number of excitation = 1. Total scanning
time per sample was 10 minutes 39 seconds. For creating
color-coded T2 maps, MRI images at multiple TE were
imported into OsiriX Medical Image software with T2
mapping plug-in.
The regions of interest (ROIs) for the NP were defined
on T2-weighted images taken at a TE of 100 ms,
whereas the ROIs for the AF were defined on proton
density-weighted images taken at a TE of 20 ms. These
images were selected to best visualize the borders of the
AF and NP. Signal intensity values within each ROI
were averaged and then fit mono-exponentially to a T2
decay equation. To minimize the differences between
animals, the T2 values of each experimental disc were
normalized by that of the non-punctured disc (L3/4).
Non-responsive treated discs (which did not exhibit
degenerated MR morphology) were excluded from the
analysis (PBS group; n = 7 discs, PPP group; n = 7 discs,
PRP group; n = 8 discs).
Figure 1 Flowchart of the isolation of platelet-poor plasma (PPP) and platelet-rich plasma (PRP) releasates. During surgery, a total of 15
mL of whole blood was drawn from the femoral artery. PPP and PRP were prepared by using two separate centrifugation techniques. Five
milliliters of whole blood was used for isolating autologous serum. After clot formation by adding autologous serum and CaCl2, the PPP- and
PRP-releasates were isolated from the clotted PPP and PRP by centrifugation.
Obata et al. Arthritis Research & Therapy 2012, 14:R241
http://arthritis-research.com/content/14/6/R241
Page 3 of 11
Histological examination
After MRI assessment, the experimental IVDs were
excised from the vertebral body-disc-vertebral body unit,
and each IVD was fixed in 4% paraformaldehyde for 7
days at 4°C and then decalcified in 0.5 M ethylenediami-
netetraacetic acid (EDTA), embedded in paraffin, sec-
tioned, and assessed by conventional histology. Mid-
sagittal sections (5 μm) of each IVD were stained with
either hematoxylin and eosin or with safranin-O.
Blinded to the experiment, an observer analyzed the his-
tological sections and graded them by using the recently
established histology grading protocol [24].
The chondrocyte-like cells appeared as large cells
encircled with pericellular matrix densely stained with
safranin-O. The number of chondrocyte-like cells (more
than 2.0 μm in diameter including pericellular matrix)
in the serial sections (100 μm in width from upper to
lower endplate) of the inner anterior and posterior AF,
and the center of the NP was quantified by manually
counting the cells by using a light microscope.
Statistical analysis
The significance of differences among means of data on
radiograph measurements was analyzed by two-way
repeated measures analysis of variance (ANOVA). T2
values in MRI and the number of chondrocyte-like cells
were analyzed by one-way ANOVA and Fisher’s pro-
tected least significant difference as a post hoc test. The
data are expressed as the mean ± standard error of the
mean. Histology grading was analyzed by the Kruskal-
Wallis test and Mann-Whitney U test for the effect of
treatment. Statistical analysis was performed by using
the StatView program (version 5.0; SPSS Inc., Chicago,
IL) with a significance level of P of less than 0.05.
Results
Platelet count
The mean platelet count of PRP was about 29 times
greater than that of whole blood (whole blood: 195.2 ±
6.4 × 103/μL, PRP: 5,752.5 ± 393.7 × 103/μL, P <0.01
versus whole blood).
Radiographic assessment
In all PBS, PPP, and PRP groups, radiographs 4 weeks
after the initial anular puncture showed a significant
narrowing of disc height compared with that of the
non-punctured L3/4 disc (approximately 24.0% decrease
compared with the baseline percentage DHI values
before anular puncture, P <0.01) (Figure 2, see arrow).
There were no significant differences in the percentage
DHI among the experimental groups.
The treatment significantly affected the post-injection
disc height (two-way repeated ANOVA, P <0.001). Two
weeks after the injection of PPP- or PRP-releasate, the
disc height began to recover compared with the discs
injected with PBS (% DHI: PBS group: 70.8% ± 1.5%;
PPP group: 83.7% ± 3.0%, P <0.01; PRP group: 86.8% ±
9.3%, P <0.01 all versus PBS group) (Figure 2). Four
Figure 2 Changes in the intervertebral disc height index (DHI). Four weeks after anular puncture [Punc. (at -4 weeks)], phosphate-buffered
saline (PBS) (control) or platelet-poor plasma (PPP)- or platelet-rich plasma (PRP)-releasate was injected into the punctured discs. The percentage
DHI was measured at each time point to quantify changes in disc height. Four weeks after the injection of PRP-releasate, the percentage DHI of
injected discs in the PRP group was significantly higher than that in the PBS group (P <0.01, repeated analysis of variance). This significant
difference in the percentage DHI was sustained until 8 weeks after the injection. Values are shown as mean ± standard error of the mean. *P
<0.05, **P <0.01 versus PBS group; #P <0.05, ##P <0.01 between PPP and PRP.
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weeks after the injection, PRP-releasate induced restora-
tion of disc height to the level approaching 90% of the
non-punctured disc; this was sustained for the entire
experimental period (4W, 6W, 8W: P <0.01 versus PBS
group; 4W: P <0.05, 6W, 8W: P <0.01 versus PPP
group) (Figure 2). While the PPP group also showed a
significant recovery of disc height compared with the
PBS group, it was no more than 80% of that of the non-
punctured disc (4W, 6W, 8W: P <0.01 versus PBS
group) (Figure 2). The injection of PBS did not induce
restoration of disc height over the same time period
(Figure 2).
Magnetic resonance imaging assessment
MRI analysis was performed at 8 weeks after the PBS, PPP,
or PRP injections. Representative sagittal images of color-
coded T2 maps showed that an area with high T2 value
was identified in the NP injected with PRP-releasate
(Figure 3). The normalized T2 values of the NPs (Figure
4a) were slightly higher than those for PPP (0.32 ± 0.03)
and PRP (0.30 ± 0.02) samples compared with the values
in the PBS samples (0.28 ± 0.02) but failed to reach statis-
tical significance (P = 0.66). The normalized T2 values of
the AFs (Figure 4b) showed similar trends, being some-
what higher for PRP (0.89 ± 0.08) and PPP (0.84 ± 0.06)
compared with PBS control (0.70 ± 0.03). However,
no statistically significant treatment effect was found
(P = 0.49).
Histological evaluations
Safranin-O-stained histology in the PBS group (Figure 5c,
d) showed severely degenerated discs in which most of the
NP contents have been lost and collapsed, wavy fibrocarti-
lage lamella and associated fibrochondrocyte-like cells of
the AF. In the PPP and PRP groups, the increasing num-
bers of chondrocyte-like cells, which appear as large cells
encircled with pericellular matrix densely stained with
safranin-O, were found in either the inner AF or the NP
(Figure 5f,h, respectively). However, there were no signifi-
cant differences in the histological scores among the three
groups. In all of the experimental groups, the invasion of
blood vessels or inflammatory cells was not observed
within the discs (Figure 5c,d, Figure 5e,f, and Figure 5g,h,
respectively). Furthermore, no ossification of exclusively
IVD tissues was found in any of the samples, although
there was significant osteophyte formation at the edge of
the vertebral body (Figure 5c,e,g).
Within the present study, one of the major cellular
changes was the increasing number of chondrocyte-like
cells in the inner AF or in the NP of PRP-releasate-
injected discs, as previously reported [24]. In the ante-
rior (inner) AF, the number of chondrocyte-like cells in
the PRP group was significantly higher than those of the
PBS and PPP groups (P <0.01) (Figure 5). The injection
of the PRP-releasate significantly increased the number
of chondrocyte-like cells in the NP compared with that
of the PBS group (P <0.01), although no significant dif-
ferences were found between the PRP and PPP groups
(P = 0.06) (Figure 6). In the posterior (inner) AF, no sig-
nificant differences were found among the three groups
(Figure 6).
Discussion
This study examined the efficacy of the injection of PRP-
releasate into degenerated discs in the well-established
rabbit anular needle puncture model. The results of this
study demonstrated that the intradiscal injection of PRP-
releasate is effective for restoring disc height in this animal
model. The histological analysis also revealed a reparative
effect of PRP-releasate on the degenerated IVD.
Platelets have three major granule storage compart-
ments: alpha granules, dense granules, and lysosomes.
Alpha granules contain a large number of different secre-
tory proteins, such as growth factors, coagulation pro-
teins, adhesion molecules, cytokines, cell-activating
agents, and angiogenic factors [18]. Platelets must be
activated to release the contents of alpha granules to the
external milieu where they exert potent biological effects.
In many in vitro or in vivo studies (or both), activation of
PRP is accomplished by adding bovine or human throm-
bin with calcium chloride [8,21,22,25-28]. However, it
would be more feasible for clinical use if the concern
about immunogenic reactions or disease transmission in
using xenogeneic or allogeneic blood products were
eliminated. In addition, the use of thrombin was of con-
cern to us because thrombin has been shown to degrade
cartilage tissues [29] and to cleave the same site as plas-
min [30,31]. Therefore, in this study, we used a mixture
of autologous serum and calcium chloride for activation
of PRP.
The administration of PRP-releasate into degenerated
IVDs greatly restored the decrease in disc height follow-
ing anular needle puncture in this in vivo rabbit model.
In a previous study using the same animal model, the
injection of OP-1 [11] or growth differentiation factor-5
(GDF-5) [24] induced restoration of disc height to a
level approaching 90% of that of a normal non-punctu-
red disc. The results of our study suggest that the
administration of PRP-releasate had an effect on the
structural restoration of disc height similar to those of
OP-1 or GDF-5 or both.
The major advantage of using PRP over purified
growth factors is that PRP can be isolated from an auto-
logous source, thus eliminating concerns about the
potential for cancer [32] or autoantibodies. In addition,
the preparation of PRP can be performed in a regular
hospital setting with a minimum requirement for equip-
ment and less vigorous regulatory oversight. However,
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Figure 3 Representative sagittal magnetic resonance T2-weighted images (left panels) and T2 maps (right panels) of rabbit lumbar
spines. The lower four images are magnifications (4×) of those discs in the upper two T2 maps: (a) non-punctured control (L3/4), (b)
phosphate-buffered saline (PBS) (control) group, (c) platelet-poor plasma (PPP)-releasate group, and (d) platelet-rich plasma (PRP)-releasate group.
The T2 values in the nucleus pulposus (NP) are significantly lower in all punctured discs (b-d) compared with non-punctured discs (a). However,
areas with high T2 values area are identified in the center of the NPs injected with (c) PPP- and (d) PRP-releasates.
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Figure 4 Magnetic resonance imaging results of normalized T2 values. Magnetic resonance imaging (MRI) analysis was performed at 8
weeks after the phosphate-buffered saline (PBS) (control), platelet-poor plasma (PPP)-releasate, and platelet-rich plasma (PRP)-releasate injections.
The normalized T2 value of the PBS group was the lowest on average, but no statistical significance was found. Values are shown as mean ±
standard error of the mean (SEM): PBS; n = 7 discs, PPP; n = 7 discs, PRP; n = 8 discs.
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the inter-individual variability in the concentration of
growth factors found in PRP, compared with the well-
controlled recombinant growth factors currently in clini-
cal trials (OP-1 and GDF-5), may result in inconsistent
effects.
MRI has recently been used not only for morphologi-
cal evaluation but also for characterization of the
structural organization and matrix content of the IVD.
The T2 mapping technique has shown its potential to
quantitatively evaluate changes in the molecular compo-
sition and structural organization of the IVD [33-36]. In
our study, the T2 mapping technique was used to detect
and quantify changes in the matrix structure and integ-





























Figure 5 Typical histological changes after injections of phosphate-buffered saline (PBS) (c,d), platelet-poor plasma (PPP)-releasate (e,
f), or platelet-rich plasma (PRP)-releasate (g,h). On safranin-O-stained sections, a moderate-to-severe degeneration was observed in the PBS
(c,d) and PPP (e,f) groups. In the PRP group, the increasing number of chondrocyte-like cells which appeared as large cells encircled with
pericellular matrix densely stained with safranin-O were found in the nucleus pulposus (h). The histology of the non-punctured control (L3/4) is
shown in (a,b). (b,d,f,h) are magnification images of the area indicated by a square (a,c,e,g), respectively. Scale bars: 1 mm (a,c,e,g) and 5 μm (b,d,
f,h). Asterisk indicates osteophyte formation.
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PPP- and PRP-releasate. Our results showed that the
mean T2 value in the AF and NP region of the PRP
group was not increased significantly over other groups,
even though a minor increase was seen. Additional sam-
ples may be needed to show treatment effects on T2
values, which may have been subtle.
The histological analyses showed that the injection of
PRP-releasate induced an increase in the number of
chondrocyte-like cells in the NP and the anterior inner
AF, and this suggests tissue phenotype changes from
fibrotic tissue to cartilaginous tissue. No inflammatory
reactions, such as invasion of inflammatory cells or
microvessels (or both), or ossification within the IVD
tissue was found, suggesting that PRP-releasate had no
adverse effects on disc tissues.
In the radiographic and histological analyses, PPP-
releasate also induced a reparative effect on degenerated
IVDs, although its effect was less than those of the PRP-
releasate. Previous in vitro studies [21,22] have shown
that PPP has effects on cell proliferation and matrix
metabolism similar to those of fetal bovine serum,
which is the most widely used serum supplement for in
vitro cell culture; this suggests that PPP also contains
growth factors and has the potential to stimulate the
matrix metabolism of degenerated IVDs.
In the past, two different groups have performed in
vivo intradiscal injection studies by using PRP to evalu-
ate its effect on disc degeneration in animal models.
Chen and colleagues [8] reported the effect of PRP on
disc degeneration both in an ex vivo organ culture sys-
tem and an in vivo porcine disc degeneration model.
The releasate isolated from clotted PRP, which was
induced by addition of bovine thrombin, was injected
into the degenerated disc induced by chymopapain. In
their study, PRP, which was shown to promote NP
regeneration, also resulted in the upregulation of chon-
drogenesis and extracellular matrix accumulation. In the
in vivo model, the recovery of disc height was not signif-
icant (P = 0.5). This may be due to the use of thrombin.
With consideration for a future clinical application, we
have decided not to use thrombin, but rather autologous
serum and calcium, to activate PRP.
The other group [37,38] reported in vivo intradiscal
injection studies using PRP-impregnated biodegradable
gelatin hydrogel microspheres (PRP-GHMs) in a rabbit
disc degeneration model induced by the partial aspira-
tion of the NP with a 21-gauge needle. Two weeks after
the initial surgery, autologous PRP alone or PRP-GHMs
were injected into the degenerated discs. Contrary to
the results of our study, the progression of disc degen-
eration was significantly suppressed by the combined
administration of PRP-GHMs but not by PRP alone.
Possible explanations for the conflicting findings con-
cerning the effect of PRP would be, first, the differing
methods used in the processing the injectable agents.
We injected PRP-releasate isolated from activated plate-
lets into the degenerated disc, whereas in the study by
Nagae and colleagues [37], the PRP alone injected into
the degenerated disc was prepared without platelet acti-
vation (without coagulation). Indeed, in an article just
published, DeLong and colleagues [39] state that the
manner in which platelet activation occurs is a variable
Figure 6 The number of chondrocyte-like cells after injections of phosphate-buffered saline (PBS) (control), platelet-poor plasma
(PPP)-releasate, or platelet-rich plasma (PRP)-releasate. The numbers of chondrocyte-like cells in the inner anterior and posterior anulus
fibrosus (AF) and the center of the nucleus pulposus (NP) were manually counted by using light microscopy. In the anterior AF, the number of
chondrocyte-like cells in the PRP group was significantly higher than those of the PBS and PPP groups (P <0.01). The injection of PRP-releasate
significantly increased the number of chondrocyte-like cells in the NP compared with that of the PBS group (P <0.01). Values are shown as mean
± standard error of the mean.
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that determines the efficacy of PRP; they propose a clas-
sification system for PRP publications that includes ‘pla-
telet activation manner’. Second, differences in the disc
degeneration animal models and evaluation methods
could be reflected in the conflicting results. The anular
puncture model has been shown to induce controlled
and progressive disc degeneration and effectively detect
the therapeutic effects [11,24,40]. A controlled degree of
disc degeneration may be required to test the effects of
biological therapies.
A limitation of this study is that the well-characterized
rabbit anular puncture model [23] used is a short-term
(1-month) injury animal model of disc degeneration.
Although this model does not truly reflect the course of
human disc degeneration, similar histological and bio-
mechanical changes have been previously reported
[11,23,24] and confirmed in this study. Therefore, the
results of this study may contribute to the understand-
ing of the cellular responses and the mechanism of the
repair process after PRP application in degenerative
discs.
Conclusions
We have shown that the administration of autologous
PRP-releasate was effective in restoring disc height and
increasing chondrocytic cells in the IVD of the rabbit
anular puncture disc degeneration model. Importantly,
the PRP-releasate prepared in this study was isolated
from autologous PRP, which was activated without
using xenogeneic or allogeneic blood products. The
results of this study showing that the application of
autologous PRP-releasate is effective for IVD therapy
could provide valuable information for the consideration
of PRP for a clinical application.
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